[go: up one dir, main page]

AU2003227510A1 - Novel carbapenem compounds - Google Patents

Novel carbapenem compounds

Info

Publication number
AU2003227510A1
AU2003227510A1 AU2003227510A AU2003227510A AU2003227510A1 AU 2003227510 A1 AU2003227510 A1 AU 2003227510A1 AU 2003227510 A AU2003227510 A AU 2003227510A AU 2003227510 A AU2003227510 A AU 2003227510A AU 2003227510 A1 AU2003227510 A1 AU 2003227510A1
Authority
AU
Australia
Prior art keywords
carbapenem compounds
novel carbapenem
novel
compounds
carbapenem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003227510A
Inventor
Akira Sasaki
Makoto Sunagawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharma Co Ltd
Original Assignee
Sumitomo Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Pharmaceuticals Co Ltd filed Critical Sumitomo Pharmaceuticals Co Ltd
Publication of AU2003227510A1 publication Critical patent/AU2003227510A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003227510A 2002-04-19 2003-04-16 Novel carbapenem compounds Abandoned AU2003227510A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002117479 2002-04-19
JP2002-117479 2002-04-19
PCT/JP2003/004860 WO2003089431A1 (en) 2002-04-19 2003-04-16 Novel carbapenem compounds

Publications (1)

Publication Number Publication Date
AU2003227510A1 true AU2003227510A1 (en) 2003-11-03

Family

ID=29243496

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003227510A Abandoned AU2003227510A1 (en) 2002-04-19 2003-04-16 Novel carbapenem compounds

Country Status (3)

Country Link
JP (1) JPWO2003089431A1 (en)
AU (1) AU2003227510A1 (en)
WO (1) WO2003089431A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7468364B2 (en) 2003-04-08 2008-12-23 Dainippon Sumitomo Pharma Co., Ltd. Carbapenem compounds
US7687490B2 (en) 2005-04-12 2010-03-30 Meiji Seika Kaisha, Ltd. 2-thioethenyl substituted carbapenem derivatives
JPWO2006109823A1 (en) * 2005-04-12 2008-11-20 明治製菓株式会社 2-position thioethenyl carbapenem derivatives
EP1870412A4 (en) * 2005-04-12 2009-12-30 Meiji Seika Kaisha 2-thioethenyl carbapenem derivative
JP2007039383A (en) * 2005-08-03 2007-02-15 Dainippon Sumitomo Pharma Co Ltd Method for producing aryl carbapenem compound
DE602007014256D1 (en) * 2006-12-04 2011-06-09 Astrazeneca Ab ANTIBACTERIAL POLYCYCLIC UREA COMPOUNDS
JP5342450B2 (en) * 2006-12-15 2013-11-13 ブリストル−マイヤーズ スクイブ カンパニー Arylpropionamide, arylacrylamide, arylpropinamide, or arylmethylurea analogs as factor XIa inhibitors
US10519161B2 (en) 2012-10-29 2019-12-31 Southern Methodist University Methods of generating beta-lactamase resistant carbapenem compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5409920A (en) * 1990-10-05 1995-04-25 Merck & Co., Inc. 2-(3-pyridyl)-carbapenem antibacterial agents

Also Published As

Publication number Publication date
JPWO2003089431A1 (en) 2005-08-25
WO2003089431A1 (en) 2003-10-30

Similar Documents

Publication Publication Date Title
AU2003266949A1 (en) Compounds
AU2003221098A1 (en) Oligofluorenylene compounds
AU2003279366A1 (en) Novel compounds
AU2003224111A1 (en) Substituted pyrazolo-pyrimidine-4-ones
AU2003262244A1 (en) Nitrogen-containing compounds
WO2003072535A8 (en) Substituted hydroxyethylamines
AU2003238043A1 (en) Substituted imidazotriazines
AU2003245984A1 (en) Hetero-cyclicaly substituted imidazotriazines
AU2003294900A1 (en) Substituted 5-aminomethyl-1h-pyrrole-2-carboxamides
AU2002952355A0 (en) Cephem compounds
AU2003212366A1 (en) Substituted 4-aminocyclohexanols
AU2003216859A1 (en) Amidoacetonitrile compounds
AU2003227510A1 (en) Novel carbapenem compounds
AU2003302403A1 (en) Antibacterial compounds
AU2003280578A1 (en) Heterocyclic compounds
AUPS044102A0 (en) New compound
AU2002951868A0 (en) Compound i
AU2003251259A1 (en) Novel compounds
AU2003292667A1 (en) Benzocycloheptapyridine compounds
AU2003255322A1 (en) Compounds
AU2003275480A1 (en) Compounds
AU2003226541A1 (en) Novel compounds
AU2002343838A1 (en) Novel carbapenem compounds
HK1082763A (en) Novel compounds
HK1073249A (en) Novel compounds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase